Table 1 Patient, disease and treatment characteristics
SLNB | Group 1 (n = 12) | Group 2A&B (n = 14) | Group 2C (n = 4) | p value |
|---|---|---|---|---|
Age (years) | 0.793 | |||
Median (range) | 50 (28–79) | 52.5 (27–82) | 55 (51–67) | |
Primary vulvar tumor location | 0.553 | |||
Midline | 9 (75%) | 11 (78.6%) | 4 (100%) | |
Lateralized | 3 (25%) | 3 (21.4%) | 0 | |
Diameter (mm) | 0.7645 | |||
Median (range) | 15.5 (6.0–54.0) | 19.5 (9.0–60.0) | 22.5 (16.0–35.0) | |
Diameter categories | 0.246 | |||
< 20 mm | 7 (58.3%) | 7 (50%) | 1 (25%) | |
≥ 20 mm but < 40 mm | 3 (25%) | 5 (35.7%) | 3 (75%) | |
≥ 40 mm | 2 (16.7%) | 2 (14.3%) | 0 | |
Depth (mm) | 0.0038* | |||
Median (range) | 3.0 (1.8–6.0) | 6.0 (2.0–15.0) | 8.5 (5.0–23.0) | |
Grade | 0.410 | |||
1 | – | – | – | |
2 | 10 (83.3%) | 11 (78.6%) | 2 (50%) | |
3 | 2 (16.7%) | 3 (21.4%) | 2 (50%) | |
Radiotherapy | 4 (33.3%) | 6 (42.9%) | 3 (75%) | |
Chemotherapy | 0 | 2 (14.3) | 2 (50%) | |
Local recurrence | 1 (8.3%) | 1 (7.1%) | 1 (25%) | |
Groin recurrence | 1 (8.3%) | 0 | 0 | |
(fat tissue) | ||||
Distant metastases | 1 (8.3%) | 0 | 1 (25%) |